News

AAVL

IPO Report: Avalanche Biotechnologies (AAVL)

Francis Gaskins | Equities.com |

Avalanche Biotechnologies (AAVL) is a clinical-stage biotechnology company focused on discovering and developing novel gene therapies to transform the lives of patients with sight-threatening


20 New IPOs for Week of July 28

Francis Gaskins | Equities.com |

Full IPO calendar & reports HERE.  In order of largest IPO first:   (1) Based in Stamford, CT, Synchrony Financial (SYF) scheduled a $3.06 billion IPO on the NYSE with a market


GDP, Consumer Spending in Focus for Economic Data Week Ended May 31

Andrew Klips | Equities.com |

After taking the day off on Monday to remember the men and women who lost their lives while serving in the U.S. Armed Forces, the doors on Wall Street and Washington re-opened on Tuesday. The Dow,


Sponsored Financial Content

Market Movers